This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Guangzhou Xiangxue Pharmaceutical Co., Ltd., Hangzhou Converd Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations by Qingyong Zhang
Introduction
Qingyong Zhang is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in improving the solubility of poorly soluble drugs. With a total of 2 patents to his name, Zhang's work focuses on innovative drug formulations that enhance therapeutic efficacy.
Latest Patents
Zhang's latest patents include a pharmaceutical composition that comprises an active component KX2-361 and hydroxylpropoxyl-β-cyclodextrin. This invention addresses the challenge of solubility in poorly soluble drugs, allowing for the preparation of both intravenous and oral formulations. The second patent details an oral preparation for treating cell proliferation diseases, which also utilizes hydroxylpropoxyl-β-cyclodextrin to improve the solubility and bioavailability of KX2-361. These formulations are characterized by their stability, safety, and cost-effectiveness.
Career Highlights
Throughout his career, Qingyong Zhang has worked with prominent companies such as Guangzhou Xiangxue Pharmaceutical Co., Ltd. and Hangzhou Converd Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Zhang has collaborated with notable colleagues, including Shuiping Shi and Ronghua Zhao, to advance his research and development efforts in the pharmaceutical sector.
Conclusion
Qingyong Zhang's contributions to pharmaceutical innovations demonstrate his commitment to enhancing drug formulations for better patient outcomes. His work continues to influence the field and pave the way for future advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile